Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-12-16-Speech-2-283"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2003-12-16"^^xsd:date2
dcterms:Is Part Of	lp_eu:Medicinal products2
dcterms:Language	"nl"^^xsd:language2
lpv:document identification number	"en.20031216.6.2-283"2
lpv:hasSubsequent	lp_eu:2003-12-16-Speech-2-2842
lpv:speaker	lp:Dorette Corbey2
lpv:spokenAs	substitute; Delegation to the EU-Turkey Joint Parliamentary Committee (2002-02-07--2004-07-19)3 unknown; Partij van de Arbeid (1999-07-20--2004-07-19)3 substitute; Committee on Industry, External Trade, Research and Energy (2002-01-17--2004-07-19)3 member; PES (1999-07-20--2004-07-19)3 member; Committee on the Environment, Public Health and Consumer Policy (2002-01-17--2004-07-19)3
lpv:translated text	"Mr President, it is a question to the Commissioner. My question to the Commissioner was crystal clear, and I should like a little bit more clarification on this. Just to make sure we are all singing from the same hymn sheet: the Doha amendment serves to enable manufacture for developing countries lacking that capacity themselves. Am I to understand from your answer that we are sending unauthorised medicinal products to developing countries? If so, those developing countries must then authorise them themselves, but how can they do this if they ..."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph